Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracavernosal therapy: when oral agents fail.

A Nehra1

  • 1Department of Urology, Mayo Medical School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. nehra.ajay@mayo.edu

Current Urology Reports
|June 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep disorders in pregnancy and their association with pregnancy outcomes: a prospective observational study.

Sleep & breathing = Schlaf & Atmung·2015
Same author

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

International journal of clinical practice·2013
Same author

Review of erectile dysfunction and cardiovascular risk.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2013
Same author

Effect of hearing AIDS on psychosocial dysfunctioning.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2012
Same author

Psychological intervention with parents of autistic children.

Indian journal of psychiatry·2011
Same author

Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review.

International journal of impotence research·2008

Intracavernosal injections are a leading treatment for erectile dysfunction in men over 40. This therapy remains highly effective and satisfactory for patients and partners compared to newer oral and intraurethral options.

Area of Science:

  • Urology
  • Andrology
  • Men's Health

Background:

  • Erectile dysfunction (ED) prevalence increases with age, affecting many men over 40.
  • Intracavernosal injections are a primary treatment for ED, used by approximately 25% of impotent men.
  • Established in the early 1980s, injection therapy offers a safe and successful treatment option.

Purpose of the Study:

  • To evaluate the efficacy and patient satisfaction of intracavernosal injections for erectile dysfunction.
  • To compare intracavernosal therapy with newer intraurethral and oral ED treatments.

Main Methods:

  • Review of existing literature and clinical data on intracavernosal injection therapy for ED.
  • Comparative analysis of patient satisfaction and treatment outcomes between intracavernosal therapy and alternative ED treatments.

Related Experiment Videos

Main Results:

  • Intracavernosal injections have demonstrated a long history of safe and successful use.
  • Newer intraurethral and oral agents show promising but not yet comparable patient satisfaction and erectile rigidity.
  • Intracavernosal therapy continues to be a highly regarded treatment option.

Conclusions:

  • Intracavernosal injection therapy remains a cornerstone treatment for erectile dysfunction.
  • Despite advancements, intracavernosal injections offer superior patient satisfaction and reliability compared to newer ED treatments.